Lv11
60 积分 2023-06-25 加入
Application of new approach methodologies for nonclinical safety assessment of drug candidates
1个月前
已完结
A CDER perspective: Landscape of New Approach Methodologies (NAMs) submitted in drug development programs
1个月前
已完结
Gaps and challenges in nonclinical assessments of pharmaceuticals: An FDA/CDER perspective on considerations for development of new approach methodologies
1个月前
已完结
Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools
1个月前
已完结
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
1个月前
已完结
Future Directions for Quantitative Systems Pharmacology
1个月前
已完结
Modernizing Preclinical Drug Development: The Role of New Approach Methodologies
1个月前
已完结
美国FDA药品审评决策反馈机制中完整回复函制度对我国药品监管的启示
2个月前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
5个月前
已完结
皖公网安备34019202002308
